Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Santen Pharmaceutical Co., Ltd.
Age
20–74
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed with primary open-angle glaucoma or ocular hypertension.
Provided signed, written informed consent.
If a subject is a female of childbearing potential, she must utilize reliable contraceptive throughout the study, and must have a negative urine pregnancy test prior to enrollment into this study.
You may not be if
Females who are pregnant, nursing or planning a pregnancy, or females of childbearing potential who are not using a reliable method of contraception.
Presence of any abnormality or significant illness that could be expected to interfere with the study.
Clareo Health | To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension
